Tetsuo Noda Selected Research

Neoplasm Metastasis (Metastasis)

6/2022	GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.
1/2019	Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.
7/2008	HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
8/2007	MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis.
1/2007	HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuo Noda Research Topics

Disease

34	Neoplasms (Cancer) 01/2023 - 02/2003
12	Carcinogenesis 10/2021 - 09/2002
11	Insulin Resistance 10/2022 - 07/2002
11	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2020 - 01/2002
8	Obesity 01/2020 - 10/2004
6	Breast Neoplasms (Breast Cancer) 03/2023 - 12/2007
6	Deafness (Deaf Mutism) 12/2016 - 04/2002
6	Body Weight (Weight, Body) 04/2010 - 04/2002
5	Hyperglycemia 10/2023 - 06/2004
5	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2007
5	Glucose Intolerance 01/2020 - 07/2002
5	Inflammation (Inflammations) 01/2015 - 05/2010
4	Carcinoma (Carcinomatosis) 10/2021 - 01/2016
4	Tuberous Sclerosis (Bourneville's Disease) 01/2020 - 05/2008
4	Polyps 04/2004 - 09/2002
4	Intestinal Polyps 04/2004 - 09/2002
3	Rectal Neoplasms (Rectal Cancer) 01/2023 - 01/2020
3	Adenocarcinoma 01/2021 - 04/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 05/2010
3	Hyperplasia 01/2020 - 10/2004
3	Heart Failure 10/2018 - 05/2009
3	Hearing Loss (Hearing Impairment) 12/2016 - 04/2002
3	Fibrosis (Cirrhosis) 01/2015 - 02/2011
3	Infections 12/2013 - 01/2005
3	Teratozoospermia 07/2007 - 08/2002
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2019
2	Chronic Renal Insufficiency 01/2020 - 05/2014
2	Microsatellite Instability 04/2019 - 02/2012
2	Reperfusion Injury 05/2014 - 02/2011
2	Hypertrophy 01/2012 - 01/2011
2	Hyperinsulinism (Hyperinsulinemia) 01/2011 - 04/2007
2	Adenoma (Adenomas) 05/2009 - 11/2007
2	Adenocarcinoma of Lung 07/2008 - 01/2007
2	Colonic Neoplasms (Colon Cancer) 08/2007 - 02/2003
2	Type 2 Diabetes Mellitus (MODY) 04/2007 - 01/2005
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Dysbiosis 10/2023
1	Aneuploidy (Aneuploid) 11/2022
1	Sarcopenia 10/2022
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2022

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
8	Insulin (Novolin)FDA Link 10/2023 - 09/2003
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2004
7	InflammasomesIBA 01/2015 - 02/2011
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2011
6	AdiponectinIBA 01/2012 - 07/2002
6	beta CateninIBA 10/2009 - 01/2002
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2011
5	CytokinesIBA 12/2018 - 10/2004
5	CateninsIBA 10/2018 - 11/2010
5	Connexin 26IBA 12/2016 - 04/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 10/2004
4	TOR Serine-Threonine KinasesIBA 01/2018 - 08/2005
4	ConnexinsIBA 07/2015 - 01/2014
4	EnzymesIBA 01/2013 - 04/2002
4	AMP-Activated Protein KinasesIBA 01/2012 - 03/2006
3	Insulin ReceptorIBA 10/2023 - 10/2016
3	ChromatinIBA 03/2023 - 06/2022
3	ElementsIBA 03/2023 - 09/2003
3	NucleotidesIBA 11/2022 - 05/2010
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2015
3	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 10/2014 - 03/2010
3	Small Interfering RNA (siRNA)IBA 04/2012 - 07/2008
3	LeptinIBA 01/2012 - 10/2004
3	Triglycerides (Triacylglycerol)IBA 07/2008 - 09/2003
2	Immunoglobulin G (IgG)IBA 01/2022 - 05/2004
2	Transforming Growth Factor-beta Type II ReceptorIBA 10/2021 - 02/2012
2	Adenosine Triphosphatases (ATPase)IBA 01/2016 - 04/2002
2	InterleukinsIBA 01/2015 - 07/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 02/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 04/2002
2	LigandsIBA 07/2013 - 09/2003
2	LipidsIBA 01/2013 - 09/2003
2	MesothelinIBA 04/2012 - 04/2011
2	Messenger RNA (mRNA)IBA 01/2012 - 05/2003
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2012 - 07/2007
2	Retinaldehyde (Retinal)IBA 03/2010 - 11/2003
2	Bromodeoxyuridine (BrdU)IBA 10/2009 - 09/2002
2	Indicators and Reagents (Reagents)IBA 07/2008 - 01/2007
2	GlucokinaseIBA 04/2007 - 06/2004
2	Pioglitazone (Actos)FDA Link 03/2006 - 09/2003
2	Protein Isoforms (Isoforms)IBA 01/2005 - 09/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2004 - 09/2002
2	Cyclooxygenase 1IBA 04/2004 - 09/2002
2	nimesulide (Aulin)IBA 04/2004 - 09/2002
2	mofezolacIBA 04/2004 - 09/2002
2	Cholecystokinin A ReceptorIBA 10/2003 - 07/2002
2	CholesterolIBA 10/2003 - 09/2003
2	ProstaglandinsIBA 07/2003 - 09/2002
1	PhlorhizinIBA 10/2023
1	Streptozocin (Streptozotocin)FDA Link 10/2023
1	Antimicrobial PeptidesIBA 10/2023

Therapy/Procedure

8	Therapeutics 08/2022 - 01/2015
6	Drug Therapy (Chemotherapy) 08/2022 - 05/2010
3	Neoadjuvant Therapy 01/2023 - 12/2007
3	Chemoprevention 05/2009 - 07/2003
2	Lasers (Laser) 12/2007 - 08/2007